Anti-neoplastic agents
Showing 1 - 25 of >10,000
Tumors Trial run by the NCI (Nilotinib and Paclitaxel)
Recruiting
- Neoplasms
- Nilotinib and Paclitaxel
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Refractory Malignant Solid Neoplasm
- Atezolizumab
- +5 more
- (no location specified)
Feb 4, 2023
Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer
Recruiting
- Adrenal Gland Pheochromocytoma
- +3 more
- Computed Tomography
- +2 more
-
Bethesda, Maryland
- +1 more
Jan 3, 2023
Based on PRO Data Reported ThroughMHealth App Solution in
Completed
- Multiple Myeloma
- mHealth app
-
Odense, DenmarkOdense University Hospital
Feb 10, 2023
Stroke, Medication Adherence Trial in Kumasi (Polycap)
Not yet recruiting
- Stroke
- Medication Adherence
-
Kumasi, GhanaKwame Nkrumah Institute of Science & Technology
Jul 19, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- INE963
- +3 more
- (no location specified)
Feb 17, 2023
Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and
Not yet recruiting
- Disability or Chronic Disease Leading to Disablement
- +2 more
- Surgical flap and anti-bacterial agents
-
Garches, FranceDepartment of Physical Medicine and Rehabilitation, Raymond Poin
Feb 1, 2023
Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)
Not yet recruiting
- Relapsed/Refractory Non-Hodgkin Lymphoma
-
Duarte, California
- +1 more
Oct 13, 2023
Anti-HLA Immunization And Immunosuppressive Therapy Management
Active, not recruiting
- Kidney Transplantation
- +3 more
- management of immunosuppressive therapy
-
Nancy, Lorraine, FranceCentral HNF
Mar 24, 2022
Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)
Recruiting
- Solid Tumor
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital
Jun 14, 2023
Atherosclerosis, Adherence, Medication, Tolerance Trial in Kumasi (Polycap)
Completed
- Atherosclerosis
- +2 more
-
Kumasi, GhanaKwame Nkrumah University of Science & Technology
Sep 29, 2022
Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)
Completed
- Crohn's Disease
- Ulcerative Colitis
- Immuno monitoring
-
Montpellier, FranceUniversity hospital
Dec 13, 2022
IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)
Not yet recruiting
- Inflammatory Bowel Diseases
- Biological Substance; Adverse Effect
- Azithromycin Pill
- Placebo
-
Haifa, IsraelRambam Health Care Campus
Oct 25, 2022
Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Canakinumab
- Placebo
-
Charlestown, Massachusetts
- +11 more
Nov 11, 2022
Risk of NSAIDs on Anastomotic Leak for Rectal Surgery
Recruiting
- Anastomotic Leak
- Anti-Inflammatory Agents, Non-Steroidal
-
Chongqing, None Selected, ChinaArmy Medical Center
Nov 24, 2023
Cancer, Radiotherapy Side Effect Trial in Montreal (Radiotherapy)
Recruiting
- Cancer
- Radiotherapy Side Effect
- Radiotherapy
-
Montreal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Mar 14, 2022
Oral Mucositis, Osteoradionecrosis, Osteonecroses, Bisphosphonate Trial in Santiago De Compostela (Preventive, LLL Phototherapy
Recruiting
- Oral Mucositis
- +6 more
- Preventive, LLL Phototherapy and topical Vit E
- +3 more
-
Santiago De Compostela, LA Coruña, SpainHospital Clinico Universitário
Feb 1, 2022
Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)
Recruiting
- Treatment Resistant Depression
- +12 more
-
Brooklyn, New YorkMaimonides Medical Center
Dec 12, 2022
PTSD, Alcohol Use Disorder Trial in Baltimore (Pregabalin plus BBCET, Placebo plus BBCET)
Active, not recruiting
- PTSD
- Alcohol Use Disorder
- Pregabalin plus BBCET
- Placebo plus BBCET
-
Baltimore, MarylandUniversity of Maryland School of Medicine
Mar 25, 2022